Concepedia

Author

Judith Carser

Queen's University Belfast

Also Known As

Elizabeth Woodward, J Carser, J. Carser, J. E. Carser, J.E. Carser, Judith Carser, Judith E. Carser, Judith Elizabeth Carser

19

Publications

412

Citations

9

H-Index

21

Concepts

All Affiliations

Queen's University BelfastRoyal Marsden NHS Foundation TrustBeatson West of Scotland Cancer CentreSheffield Teaching Hospitals NHS Foundation TrustClatterbridge Cancer Centre NHS Foundation Trust
JC

About

Judith Carser is an author at Queen's University Belfast specializing in medicine, pathology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

138

2

Pathology

3

3

109

3

Obstetrics

1

1

64

4

Rheumatology

1

1

29

5

Cancer Genetics

1

1

64

Judith Carser

×

7

Publications

309

Citations

7

H-Index

YearCitations

Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol

Gerhardt Attard, Laura Murphy, Noel W. Clarke,

The Lancet Oncology

2023

85

Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial

Janet E. Brown, Kara‐Louise Royle, Walter M. Gregory,

The Lancet Oncology

2023

76

BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer

Judith Carser, Jennifer E. Quinn, Caroline O. Michie,

Gynecologic Oncology

2011

64

Could a low-cost audio-visual link be useful in rheumatology?

Lorraine Graham, S Mcgimpsey, Stephen Wright,

Journal of Telemedicine and Telecare

2000

29

Trichomegaly of the Eyelashes After Treatment with Erlotinib in Non-small Cell Lung Cancer

Judith Carser, Yvonne Summers

Journal of Thoracic Oncology

2006

25

Trichomegaly of the Eyelashes After Treatment with Erlotinib in Non-small Cell Lung Cancer

Judith Carser, Yvonne Summers

Journal of Thoracic Oncology

2006

20

A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAFV600 mutant advanced melanoma (INTERIM)

Alimu Dayimu, Avinash Gupta, Rubeta Matin,

European Journal of Cancer

2023

10

Page 1